Dealing with melanoma has long been a experimentation process for physicians, but Champions Oncology is expected to take the think work out of selecting the right treatment through the use of its mouse avatars. Champions Oncology is an American technology company that develops mouse avatars, called TumorGrafts, used to test targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. Champions Oncology’s TumorGraft Platform and Translational Oncology Solutions is an innovative platform technology able to accelerate the development of oncology drugs by predicting their clinical effectiveness.
For more details you can visit: http://championsoncology.com/
